Inflammatory blood markers, including C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR), have emerged as promising candidates for early breast cancer detection due to their association with cancer-related inflammation and immune responses[7–10]. The gene discussed is CRP; the disease is breast cancer.